Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
CALL
Estee Lauder
EL
$37.4B
| $2.8M | ﹤0.01% |
+11,000
| New | +$2.79M |
|
3327
CALL
American Airlines Group
AAL
$9.03B
| $2.79M | ﹤0.01% |
220,400
+159,400
| +261% | +$2.65M |
|
|
DICE
3328
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $2.79M | ﹤0.01% |
179,620
-101,776
| -36% | -$1.75M |
|
3329
Aclaris Therapeutics
ACRS
$885M
| $2.77M | ﹤0.01% |
198,794
+142,581
| +254% | +$2M |
|
|
LUNA
3330
DELISTED
Luna Innovations Incorporated
LUNA
| $2.77M | ﹤0.01% |
475,221
+340,907
| +254% | +$2.01M |
|
3331
Edison International
EIX
$27B
| $2.77M | ﹤0.01% |
43,746
-60,116
| -58% | -$4.07M |
|
3332
Viemed Healthcare
VMD
$336M
| $2.77M | ﹤0.01% |
514,131
+388,790
| +310% | +$2.1M |
|
3333
iShares US Aerospace & Defense ETF
ITA
$14B
| $2.76M | ﹤0.01% |
27,870
-2,830
| -9% | -$291K |
|
3334
Middlesex Water
MSEX
$1.1B
| $2.76M | ﹤0.01% |
+31,507
| New | +$2.82M |
|
3335
Acumen Pharmaceuticals
ABOS
$211M
| $2.76M | ﹤0.01% |
+587,583
| New | +$2.21M |
|
3336
Organogenesis Holdings
ORGO
$224M
| $2.76M | ﹤0.01% |
565,802
-856,176
| -60% | -$5.27M |
|
3337
CorMedix
CRMD
$647M
| $2.76M | ﹤0.01% |
686,251
+664,473
| +3,051% | +$2.47M |
|
3338
Scilex Holding
SCLX
$38.2M
| $2.75M | ﹤0.01% |
7,670
+5,079
| +196% | +$1.81M |
|
3339
Agios Pharmaceuticals
AGIO
$1.99B
| $2.75M | ﹤0.01% |
123,830
+82,995
| +203% | +$1.87M |
|
|
CUK
3340
DELISTED
Carnival PLC
CUK
| $2.74M | ﹤0.01% |
346,671
+188,974
| +120% | +$2.55M |
|
3341
TTM Technologies
TTMI
$12.5B
| $2.73M | ﹤0.01% |
218,744
+129,200
| +144% | +$1.79M |
|
|
TGH
3342
DELISTED
Textainer Group Holdings limited
TGH
| $2.73M | ﹤0.01% |
99,667
-256,045
| -72% | -$8.27M |
|
3343
PUT
Goodyear
GT
$1.83B
| $2.73M | ﹤0.01% |
+255,000
| New | +$3.19M |
|
3344
Karyopharm Therapeutics
KPTI
$42.4M
| $2.73M | ﹤0.01% |
40,359
-43,166
| -52% | -$3.96M |
|
3345
PUT
iShares US Real Estate ETF
IYR
$4.58B
| $2.72M | ﹤0.01% |
29,600
-700,900
| -96% | -$69.9M |
|
3346
PUT
Align Technology
ALGN
$11.2B
| $2.72M | ﹤0.01% |
11,500
+9,500
| +475% | +$2.92M |
|
|
PTVE
3347
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $2.71M | ﹤0.01% |
272,527
+233,484
| +598% | +$2.35M |
|
|
FFIC
3348
DELISTED
Flushing Financial
FFIC
| $2.71M | ﹤0.01% |
127,269
+117,394
| +1,189% | +$2.57M |
|
3349
Medifast
MED
$136M
| $2.71M | ﹤0.01% |
14,991
+13,302
| +788% | +$2.38M |
|
3350
Navigator Holdings
NVGS
$1.36B
| $2.71M | ﹤0.01% |
239,661
+194,577
| +432% | +$2.52M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.